Rubric Capital Management 13F holdings, Q1 2023
Holdings as of March 31, 2023 · filings on SEC EDGAR · latest filing →
Rubric Capital Management disclosed 70 US equity positions worth $2.5bn in its Q1 2023 13F filing. The largest position was GLNG at 5.6% of the reported book, followed by STNG and CCJ. Against the Q4 2022 filing, it opened 8 new positions, added to 21 and reduced 16 among the top 50 holdings.
What did Rubric Capital Management own in Q1 2023? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2022 |
|---|---|---|---|---|---|---|---|
| 1 | GLNG GOLAR LNG LTD | Energy | 5.6% | $139.8m | 6,470,779 | 2% | added |
| 2 | STNG SCORPIO TANKERS INC | Energy | 5.4% | $135.4m | 2,404,567 | – | new |
| 3 | CCJ CAMECO CORP | Energy | 4.9% | $122.8m | 4,690,894 | 1776% | added |
| 4 | HTZ HERTZ GLOBAL HLDGS INC | Industrials | 4.2% | $105.6m | 6,480,823 | -12% | reduced |
| 5 | BGC PARTNERS INC | 4.1% | $103.8m | 19,853,149 | 9% | added | |
| 6 | FLR FLUOR CORP NEW | Industrials | 4.0% | $101.0m | 3,267,603 | -1% | reduced |
| 7 | PLAYA HOTELS & RESORTS NV | 3.6% | $91.3m | 9,507,284 | -20% | reduced | |
| 8 | PARR PAR PAC HOLDINGS INC | Energy | 3.4% | $84.7m | 2,899,942 | -5% | reduced |
| 9 | AIR AAR CORP | Industrials | 3.2% | $79.8m | 1,463,342 | -0% | held |
| 10 | COLL COLLEGIUM PHARMACEUTICAL INC | Healthcare | 3.1% | $78.5m | 3,274,168 | -2% | reduced |
| 11 | 07WA MR COOPER GROUP INC | 2.8% | $71.2m | 1,738,038 | 54% | added | |
| 12 | MATV MATIV HOLDINGS INC | Basic Materials | 2.8% | $69.8m | 3,253,103 | 8% | added |
| 13 | VST VISTRA CORP | Utilities | 2.4% | $59.1m | 2,460,665 | – | new |
| 14 | DOLE DOLE PLC | Consumer Defensive | 2.2% | $55.7m | 4,743,276 | 5% | added |
| 15 | FCNCA FIRST CTZNS BANCSHARES INC N | Financial Services | 2.1% | $51.6m | 53,058 | – | new |
| 16 | TAC TRANSALTA CORP | Utilities | 2.0% | $50.6m | 5,785,563 | -6% | reduced |
| 17 | RENEW ENERGY GLOBAL PLC | 1.8% | $45.9m | 8,165,905 | 258% | added | |
| 18 | CSTM CONSTELLIUM SE | Basic Materials | 1.8% | $45.7m | 2,990,566 | – | new |
| 19 | XPER XPERI INC | Technology | 1.7% | $42.0m | 3,843,744 | 0% | held |
| 20 | ROIV ROIVANT SCIENCES LTD | Healthcare | 1.6% | $41.3m | 5,600,000 | 87% | added |
| 21 | AHCO ADAPTHEALTH CORP | Healthcare | 1.6% | $41.2m | 3,314,090 | -12% | reduced |
| 22 | ADEA ADEIA INC | Technology | 1.6% | $40.7m | 4,592,561 | -1% | reduced |
| 23 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 1.6% | $39.8m | 4,499,806 | – | new |
| 24 | HAPN LENDINGCLUB CORP | Financial Services | 1.6% | $39.6m | 5,492,595 | -6% | reduced |
| 25 | KOP KOPPERS HOLDINGS INC | Basic Materials | 1.5% | $38.9m | 1,110,997 | -2% | reduced |
| 26 | PACTIV EVERGREEN INC | 1.5% | $38.5m | 4,815,783 | 8% | added | |
| 27 | ARQT ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 1.5% | $38.5m | 3,500,000 | 28% | added |
| 28 | CTI BIOPHARMA CORP | 1.5% | $37.6m | 8,963,256 | – | new | |
| 29 | HOLLYSYS AUTOMATION TCHNGY L | 1.4% | $34.3m | 1,976,609 | -1% | reduced | |
| 30 | OFIX ORTHOFIX MED INC | Healthcare | 1.4% | $34.2m | 2,043,714 | – | new |
| 31 | KINIKSA PHARMACEUTICALS LTD | 1.2% | $29.9m | 2,775,636 | 77% | added | |
| 32 | CMPR CIMPRESS PLC | Industrials | 1.2% | $29.1m | 664,475 | 156% | added |
| 33 | SDGR SCHRODINGER INC | Healthcare | 1.1% | $28.6m | 1,087,793 | 9% | added |
| 34 | LAUR LAUREATE EDUCATION INC | Consumer Defensive | 1.1% | $28.1m | 2,393,482 | 265% | added |
| 35 | ZYME ZYMEWORKS INC | Healthcare | 1.0% | $25.8m | 2,854,732 | -5% | reduced |
| 36 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.0% | $25.7m | 648,041 | 72% | added |
| 37 | DIGIMARC CORP NEW | 0.9% | $23.7m | 1,205,718 | -1% | reduced | |
| 38 | IDCC INTERDIGITAL INC | Technology | 0.9% | $22.9m | 314,018 | 3% | added |
| 39 | SPRY ARS PHARMACEUTICALS INC | Healthcare | 0.9% | $22.7m | 3,480,712 | 16% | added |
| 40 | OUT OUTFRONT MEDIA INC | Real Estate | 0.9% | $21.7m | 1,335,326 | – | new |
| 41 | CCO CLEAR CHANNEL OUTDOOR HLDGS | Communication Services | 0.8% | $20.9m | 17,391,427 | 0% | held |
| 42 | STRO SUTRO BIOPHARMA INC | Healthcare | 0.8% | $20.1m | 4,360,487 | 36% | added |
| 43 | POINT BIOPHARMA GLOBAL INC | 0.8% | $19.2m | 2,645,336 | 45% | added | |
| 44 | OVID OVID THERAPEUTICS INC | Healthcare | 0.7% | $18.1m | 7,001,124 | 3% | added |
| 45 | HRTX HERON THERAPEUTICS INC | Healthcare | 0.7% | $17.7m | 11,750,000 | 0% | held |
| 46 | KPTI KARYOPHARM THERAPEUTICS INC | Healthcare | 0.7% | $17.3m | 4,441,056 | -46% | reduced |
| 47 | 290A CHINOOK THERAPEUTICS INC | 0.7% | $16.7m | 719,809 | 0% | held | |
| 48 | MX MAGNACHIP SEMICONDUCTOR CORP | Technology | 0.6% | $15.6m | 1,683,462 | -14% | reduced |
| 49 | HIRERIGHT HOLDINGS CORPORATI | 0.6% | $15.3m | 1,440,037 | -5% | reduced | |
| 50 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 0.5% | $12.7m | 4,195,072 | 21% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.